153 related articles for article (PubMed ID: 17645109)
1. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
Koch M
Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
[TBL] [Abstract][Full Text] [Related]
2. [New antitumor agents in the acronycine series].
Tillequin F
Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
[TBL] [Abstract][Full Text] [Related]
3. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
Seguin E; Tillequin F
Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
[TBL] [Abstract][Full Text] [Related]
4. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
Michel S; Gaslonde T; Tillequin F
Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
[TBL] [Abstract][Full Text] [Related]
5. Acronycine derivatives: a promising series of anticancer agents.
Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
[TBL] [Abstract][Full Text] [Related]
6. [Acronycine revisited: development of benzo[b]acronycine antitumor agents].
Tillequin F; Koch M
Ann Pharm Fr; 2005 Jan; 63(1):35-43. PubMed ID: 15803099
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
[TBL] [Abstract][Full Text] [Related]
9. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
10. Antitumor psoropermum xanthones and sarcomelicope acridones: privileged structures implied in DNA alkylation.
Nguyen HT; Lallemand MC; Boutefnouchet S; Michel S; Tillequin F
J Nat Prod; 2009 Mar; 72(3):527-39. PubMed ID: 19191562
[TBL] [Abstract][Full Text] [Related]
11. 2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
Motiur Rahman AF; Liang JL; Lee SH; Son JK; Jung MJ; Kwon Y; Jahng Y
Arch Pharm Res; 2008 Sep; 31(9):1087-93. PubMed ID: 18806949
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
Thi Mai HD; Gaslonde T; Michel S; Tillequin F; Koch M; Bongui JB; Elomri A; Seguin E; Pfeiffer B; Renard P; David-Cordonnier MH; Laine W; Bailly C; Kraus-Berthier L; Léonce S; Hickman JA; Pierré A
J Med Chem; 2003 Jul; 46(14):3072-82. PubMed ID: 12825945
[TBL] [Abstract][Full Text] [Related]
13. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine.
Dheyongera JP; Geldenhuys WJ; Dekker TG; Van der Schyf CJ
Bioorg Med Chem; 2005 Feb; 13(3):689-98. PubMed ID: 15653336
[TBL] [Abstract][Full Text] [Related]
16. Acronycine derivatives as promising antitumor agents.
Guilbaud N; Léonce S; Tillequin F; Koch M; Hickman JA; Pierré A
Anticancer Drugs; 2002 Jun; 13(5):445-9. PubMed ID: 12045455
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxic activity, and mechanism of action of furo[2,3-c]acridin-6-one and benzo[b]furo[3,2-h]acridin-6-one analogues of psorospermin and acronycine.
Boutefnouchet S; Gaboriaud-Kolar N; Nguyen TM; Depauw S; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A; Tillequin F; Lallemand MC; Michel S
J Med Chem; 2008 Nov; 51(22):7287-97. PubMed ID: 18947222
[TBL] [Abstract][Full Text] [Related]
18. Chiral dihydroxylation of acronycine: absolute configuration of natural cis-1,2-dihydroxy-1,2-dihydroacronycine and cytotoxicity of (1R,2R)- and (1S,2S)-1,2-diacetoxy-1,2-dihydroacronycine.
Costes N; Michel S; Tillequin F; Koch M; Pierré A; Atassi G
J Nat Prod; 1999 Mar; 62(3):490-2. PubMed ID: 10096866
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activity of dimeric analogs of acronycine in the benzo[b]pyrano[3,2-h]acridin-7-one series.
Gaslonde T; Michel S; Koch M; Pfeiffer B; Léonce S; Pierré A; Tillequin F
Chem Pharm Bull (Tokyo); 2007 May; 55(5):734-8. PubMed ID: 17473459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
